Disc Medicine, Inc. (IRON)
71.91
+0.14
(+0.20%)
USD |
NASDAQ |
Apr 20, 14:21
Disc Medicine SG&A Expense (Quarterly) : 20.75M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amylyx Pharmaceuticals, Inc. | 15.39M |
| Eli Lilly & Co. | 3.132B |
| Masimo Corp. | 131.30M |
| Cytokinetics, Inc. | 91.72M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |